{"protocolSection": {"identificationModule": {"nctId": "NCT00583947", "orgStudyIdInfo": {"id": "091-029"}, "organization": {"fullName": "Sumitomo Pharma America, Inc.", "class": "INDUSTRY"}, "briefTitle": "A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects", "officialTitle": "A Cumulative Dose Safety and Tolerability Crossover Study of Arformoterol Tartrate Inhalation Solution and Levalbuterol Hydrochloride Inhalation Solution in Pediatric Subjects (Aged 2 to 11 Years of Age) With Asthma"}, "statusModule": {"statusVerifiedDate": "2012-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-01"}, "primaryCompletionDateStruct": {"date": "2008-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2008-12", "type": "ACTUAL"}, "studyFirstSubmitDate": "2007-12-21", "studyFirstSubmitQcDate": "2007-12-21", "studyFirstPostDateStruct": {"date": "2008-01-02", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2009-11-30", "resultsFirstSubmitQcDate": "2010-01-19", "resultsFirstPostDateStruct": {"date": "2010-02-08", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2012-02-21", "lastUpdatePostDateStruct": {"date": "2012-02-22", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Sumitomo Pharma America, Inc.", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "To determine the safety and tolerability of Arformoterol Tartrate in children with asthma", "detailedDescription": "A randomized, double-blind two-way crossover study of three cumulative doses of arformoterol (7.5 ug per nebulization) and levalbuterol (0.63 mg per nebulization) given over a one hour period, followed by a single open-label treatment day with three cumulative doses of arformoterol 15 ug in subjects 2-11 years of age with asthma. This study was previously posted by Sepracor Inc. In October 2009, Sepracor Inc. was acquired by Dainippon Sumitomo Pharma., and in October 2010, Sepracor Inc's name was changed to Sunovion Pharmaceuticals Inc."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Asthma", "Respiratory Tract Diseases"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "TRIPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 53, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "ARF/LEV", "type": "OTHER", "description": "Cross-over phase: one day active treatment with arformoterol 7.5 microgram per nebulization followed by a 7 day washout. Then a one day active treatment with levalbuterol 0.63 milligram per nebulization.\n\nOpen-label phase: Following another 7 day washout, one day treatment with arformoterol 15 micrograms per nebulization.", "interventionNames": ["Drug: arformoterol", "Drug: levalbuterol"]}, {"label": "LEV/ARF", "type": "OTHER", "description": "Cross-over phase: one day active treatment with levalbuterol 0.63 milligram per nebulization followed by a 7 day washout. Then a one day active treatment with arformoterol 7.5 micrograms per nebulization.\n\nOpen-label phase: Following another 7 day washout, one day treatment with arformoterol 15 micrograms per nebulization.", "interventionNames": ["Drug: arformoterol", "Drug: levalbuterol"]}], "interventions": [{"type": "DRUG", "name": "arformoterol", "description": "Arformoterol is given at a 7.5 ug per dosing during the cross-over phase and 15 ug per dosing during the open-label phase. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).", "armGroupLabels": ["ARF/LEV", "LEV/ARF"], "otherNames": ["Brovana"]}, {"type": "DRUG", "name": "levalbuterol", "description": "Levalbuterol is given at a 0.63 mg per dosing during the cross-over phase. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).", "armGroupLabels": ["ARF/LEV", "LEV/ARF"], "otherNames": ["Xopenex"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Mean Heart Rate", "description": "Heart rate measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).", "timeFrame": "predose, various timeframes up to 5 hours post last dose"}, {"measure": "Change From Predose in Mean Heart Rate", "description": "Heart rate measured at various timepoints minus the heart rate at predose.", "timeFrame": "predose, various timeframes up to 5 hours post last dose"}, {"measure": "Mean Systolic Blood Pressure", "description": "Systolic blood pressure measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).", "timeFrame": "predose, various timeframes up to 5 hours post last dose"}, {"measure": "Change From Predose in Mean Systolic Blood Pressure", "description": "Mean systolic blood pressure measured at various timepoints minus the mean systolic blood pressure at predose", "timeFrame": "predose, various timeframes up to 5 hours post last dose"}, {"measure": "Mean Diastolic Blood Pressure", "description": "Diastolic blood pressure measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).", "timeFrame": "predose, various timeframes up to 5 hours post last dose"}, {"measure": "Change From Predose in Mean Diastolic Blood Pressure", "description": "Mean diastolic blood pressure measured at various timepoints minus the predose diastolic blood pressure", "timeFrame": "predose, various timeframes up to 5 hours post last dose"}, {"measure": "Mean Serum Potassium Levels", "timeFrame": "Predose, 2 hours and 6 hours postdose 1"}, {"measure": "Change From Predose in Mean Serum Potassium", "description": "Change in mean serum potassium at the specified timepoint minus the predose value.", "timeFrame": "predose, 2 and 6 hours post dose"}, {"measure": "Mean Serum Glucose Values", "timeFrame": "Predose, 2 and 6 hours post dose 1"}, {"measure": "Change From Predose in Mean Serum Glucose", "description": "Change in mean serum glucose at the specified timepoint minus the predose value.", "timeFrame": "predose, 2 and 6 hours post dose"}], "secondaryOutcomes": [{"measure": "Mean Forced Expiratory Volume in One Second(FEV1)", "description": "Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer.", "timeFrame": "predose, various postdose times"}, {"measure": "Change From Predose of Mean Forced Expiratory Volume in One Second (FEV1)", "description": "Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. Change in FEV1 was calculated as postdose value minus the predose value at each visit.", "timeFrame": "predose, various postdose timepoints"}, {"measure": "Mean Peak Expiratory Flow Rate (PEFR)", "description": "PEFR is the fastest rate at which air can move through the airways during a forced expiration starting with fully inflated lungs as measured by peak flow meters.", "timeFrame": "predose, various postdose times"}, {"measure": "Change From Predose in Mean Peak Expiratory Flow Rate (PEFR)", "description": "PEFR is the fastest rate at which air can move through the airways during a forced expiration starting with fully inflated lungs as measured by peak flow meters. Change in PEFR was calculated as postdose value minus the predose value at each visit.", "timeFrame": "predose, various postdose times"}, {"measure": "Plasma Concentration of (R,R) Formoterol", "description": "If the mean plasma concentration was 'below the limit of quantification' (BLQ) which was set as \\<=0.5 picograms/milliliter, the value is displayed as a zero.", "timeFrame": "predose, various postdose times"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Male and Female\n* Between Age 2 and 11, inclusive, at the time of consent\n* Weight equal to or greater than 15 Kg\n* History of physician-diagnosed asthma of at least 2 years duration for children age 6 and older, and at least 1 year duration for children 5 and younger.\n\nExclusion Criteria:\n\n* Female subject who is pregnant or lactating.\n* Subject who has a history of hospitalization for asthma within one year, or who is scheduled for in-patient hospitalization, including elective surgery during the course of the trial.\n* Subject with any history of life-threatening asthma defined as a history of asthma episodes requiring intubation, associated with hypercapnia, respiratory arrest, or hypoxic seizures.\n* Subject with a history of cancer.\n* Subject with hyperthyroidism, diabetes, hypertension, cardiac diseases or seizure disorders.\n* Subject with a history of cigarette smoking or use of any tobacco products.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "2 Years", "maximumAge": "11 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Pulmonary Medical Director", "affiliation": "Unicorn Pharma Consulting", "role": "STUDY_CHAIR"}], "locations": [{"city": "Beverly Hills", "state": "California", "zip": "90211", "country": "United States", "geoPoint": {"lat": 34.07362, "lon": -118.40036}}, {"city": "Orange", "state": "California", "zip": "92868", "country": "United States", "geoPoint": {"lat": 33.78779, "lon": -117.85311}}, {"city": "Savannah", "state": "Georgia", "zip": "31406", "country": "United States", "geoPoint": {"lat": 32.08354, "lon": -81.09983}}, {"city": "Normal", "state": "Illinois", "zip": "61761", "country": "United States", "geoPoint": {"lat": 40.5142, "lon": -88.99063}}, {"city": "Oklahoma City", "state": "Oklahoma", "zip": "73112", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"city": "Oklahoma City", "state": "Oklahoma", "zip": "73120", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"city": "Medford", "state": "Oregon", "zip": "97504", "country": "United States", "geoPoint": {"lat": 42.32652, "lon": -122.87559}}, {"city": "Portland", "state": "Oregon", "zip": "97213", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"city": "Upland", "state": "Pennsylvania", "zip": "19013", "country": "United States", "geoPoint": {"lat": 39.85261, "lon": -75.38269}}, {"city": "Orangeburg", "state": "South Carolina", "zip": "29118", "country": "United States", "geoPoint": {"lat": 33.49182, "lon": -80.85565}}, {"city": "Spartanburg", "state": "South Carolina", "zip": "29303", "country": "United States", "geoPoint": {"lat": 34.94957, "lon": -81.93205}}, {"city": "Dallas", "state": "Texas", "zip": "75230", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"city": "Burke", "state": "Virginia", "zip": "22015", "country": "United States", "geoPoint": {"lat": 38.79345, "lon": -77.27165}}, {"city": "Richmond", "state": "Virginia", "zip": "23229", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}]}, "referencesModule": {"references": [{"pmid": "21584948", "type": "RESULT", "citation": "Hinkle J, Hinson J, Kerwin E, Goodwin E, Sciarappa K, Curry L, Hanrahan JP. A cumulative dose, safety and tolerability study of arformoterol in pediatric subjects with stable asthma. Pediatr Pulmonol. 2011 Aug;46(8):761-9. doi: 10.1002/ppul.21446. Epub 2011 May 16."}], "seeAlsoLinks": [{"label": "Xopenex HCI Patient Prescribing Information", "url": "http://www.xopenex.com/search/searchResult.cfm#precautionsInhalationSolution"}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "86 subjects were screened: 23 subjects aged 2-5 years and 63 subjects aged 6-11 years.", "groups": [{"id": "FG000", "title": "ARF/LEV", "description": "Cross-over period: one day active treatment with arformoterol 7.5 microgram per nebulization followed by a 7 day washout. Then a one day active treatment with levalbuterol 0.63 milligram per nebulization.\n\nOpen-label period: Following another 7 day washout, one day treatment with arformoterol 15 micrograms per nebulization."}, {"id": "FG001", "title": "LEV/ARF", "description": "Cross-over period: one day active treatment with levalbuterol 0.63 milligram per nebulization followed by a 7 day washout. Then a one day active treatment with arformoterol 7.5 micrograms per nebulization.\n\nOpen-label period: Following another 7 day washout, one day treatment with arformoterol 15 micrograms per nebulization."}], "periods": [{"title": "Cross-over Period", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "comment": "Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years", "numSubjects": "27"}, {"groupId": "FG001", "comment": "Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years", "numSubjects": "26"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "22"}, {"groupId": "FG001", "numSubjects": "24"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "2"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Did not meet-no longer met entry criteri", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Other", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}]}]}, {"title": "Washout", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "22"}, {"groupId": "FG001", "numSubjects": "24"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "22"}, {"groupId": "FG001", "numSubjects": "24"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}, {"title": "Open Label Period", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "comment": "3 subjects were dosed with arformoterol 7.5 microgram in error", "numSubjects": "22"}, {"groupId": "FG001", "comment": "3 subjects were dosed with arformoterol 7.5 microgram in error", "numSubjects": "24"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "22"}, {"groupId": "FG001", "numSubjects": "24"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "ARF/LEV", "description": "Cross-over: Participants treated with arformoterol 7.5 microgram per nebulization; 7 day washout; levalbuterol 0.63 milligram per nebulization.\n\nOpen label: 7 day washout; arformoterol 15 microgram per nebulization."}, {"id": "BG001", "title": "LEV/ARF", "description": "Cross-over: Participants treated with levalbuterol 0.63 milligram per nebulization; 7 day washout; arformoterol 7.5 microgram per nebulization.\n\nOpen label: 7 day washout; arformoterol 15 microgram per nebulization."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "27"}, {"groupId": "BG001", "value": "26"}, {"groupId": "BG002", "value": "53"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "27"}, {"groupId": "BG001", "value": "26"}, {"groupId": "BG002", "value": "53"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Age Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"title": "Age 2-5 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "4.4", "spread": "0.79"}, {"groupId": "BG001", "value": "4.4", "spread": "0.79"}, {"groupId": "BG002", "value": "4.4", "spread": "0.76"}]}]}, {"title": "Age 6-11 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "9.0", "spread": "1.26"}, {"groupId": "BG001", "value": "8.5", "spread": "1.43"}, {"groupId": "BG002", "value": "8.8", "spread": "1.35"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "25"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "28"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "White/Caucasian", "categories": [{"measurements": [{"groupId": "BG000", "value": "19"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "31"}]}]}, {"title": "Black/African American", "categories": [{"measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "20"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "2"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "27"}, {"groupId": "BG001", "value": "26"}, {"groupId": "BG002", "value": "53"}]}]}]}, {"title": "Height", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "centimeters", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "131.62", "spread": "15.244"}, {"groupId": "BG001", "value": "130.42", "spread": "15.377"}, {"groupId": "BG002", "value": "131.03", "spread": "15.174"}]}]}]}, {"title": "Weight", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kilograms", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "31.57", "spread": "12.106"}, {"groupId": "BG001", "value": "32.68", "spread": "12.802"}, {"groupId": "BG002", "value": "32.12", "spread": "12.345"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Mean Heart Rate", "description": "Heart rate measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).", "populationDescription": "Intent to treat population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "beats per minute", "timeFrame": "predose, various timeframes up to 5 hours post last dose", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "40"}]}], "classes": [{"title": "Predose (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "87.6", "spread": "12.56"}, {"groupId": "OG001", "value": "84.7", "spread": "14.11"}, {"groupId": "OG002", "value": "87.0", "spread": "17.47"}]}]}, {"title": "15 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "89.3", "spread": "15.57"}, {"groupId": "OG001", "value": "85.2", "spread": "15.19"}, {"groupId": "OG002", "value": "89.4", "spread": "16.88"}]}]}, {"title": "30 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "90.9", "spread": "14.47"}, {"groupId": "OG001", "value": "86.6", "spread": "14.63"}, {"groupId": "OG002", "value": "89.5", "spread": "15.59"}]}]}, {"title": "60 min post dose 1 (n=51,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "96.4", "spread": "12.33"}, {"groupId": "OG001", "value": "89.0", "spread": "13.67"}, {"groupId": "OG002", "value": "93.5", "spread": "16.41"}]}]}, {"title": "15 min post dose 2 (n=50,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "95.4", "spread": "12.94"}, {"groupId": "OG001", "value": "87.5", "spread": "14.88"}, {"groupId": "OG002", "value": "92.5", "spread": "18.60"}]}]}, {"title": "30 min post dose 2 (n=47,50,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "97.1", "spread": "13.28"}, {"groupId": "OG001", "value": "88.9", "spread": "13.33"}, {"groupId": "OG002", "value": "93.3", "spread": "16.72"}]}]}, {"title": "60 min post dose 2 (n=46,50,37)", "categories": [{"measurements": [{"groupId": "OG000", "value": "100.4", "spread": "16.60"}, {"groupId": "OG001", "value": "89.3", "spread": "13.97"}, {"groupId": "OG002", "value": "96.1", "spread": "12.80"}]}]}, {"title": "30 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "99.2", "spread": "17.38"}, {"groupId": "OG001", "value": "90.3", "spread": "14.24"}, {"groupId": "OG002", "value": "96.1", "spread": "13.92"}]}]}, {"title": "60 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "96.0", "spread": "16.45"}, {"groupId": "OG001", "value": "93.3", "spread": "13.06"}, {"groupId": "OG002", "value": "97.1", "spread": "14.95"}]}]}, {"title": "1.5 hours post last dose (n=48,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "96.2", "spread": "17.29"}, {"groupId": "OG001", "value": "91.8", "spread": "11.75"}, {"groupId": "OG002", "value": "95.3", "spread": "16.42"}]}]}, {"title": "2 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "93.0", "spread": "16.23"}, {"groupId": "OG001", "value": "91.2", "spread": "11.77"}, {"groupId": "OG002", "value": "95.9", "spread": "14.57"}]}]}, {"title": "2.5 hours post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "94.1", "spread": "16.22"}, {"groupId": "OG001", "value": "90.2", "spread": "14.61"}, {"groupId": "OG002", "value": "94.8", "spread": "15.66"}]}]}, {"title": "3 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "94.1", "spread": "14.84"}, {"groupId": "OG001", "value": "90.6", "spread": "13.57"}, {"groupId": "OG002", "value": "93.4", "spread": "16.04"}]}]}, {"title": "3.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "93.3", "spread": "14.65"}, {"groupId": "OG001", "value": "89.8", "spread": "13.20"}, {"groupId": "OG002", "value": "95.0", "spread": "15.16"}]}]}, {"title": "4 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "94.0", "spread": "12.68"}, {"groupId": "OG001", "value": "89.3", "spread": "11.76"}, {"groupId": "OG002", "value": "94.5", "spread": "14.94"}]}]}, {"title": "4.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "93.3", "spread": "13.71"}, {"groupId": "OG001", "value": "89.6", "spread": "12.50"}, {"groupId": "OG002", "value": "93.9", "spread": "16.49"}]}]}, {"title": "5 hours post last dose (n=50,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "92.4", "spread": "15.36"}, {"groupId": "OG001", "value": "89.8", "spread": "14.16"}, {"groupId": "OG002", "value": "92.9", "spread": "14.51"}]}]}]}, {"type": "SECONDARY", "title": "Mean Forced Expiratory Volume in One Second(FEV1)", "description": "Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer.", "populationDescription": "Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "liters", "timeFrame": "predose, various postdose times", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "38"}, {"groupId": "OG002", "value": "27"}]}], "classes": [{"title": "predose (n=37,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.554", "spread": "0.374"}, {"groupId": "OG001", "value": "1.552", "spread": "0.377"}, {"groupId": "OG002", "value": "1.486", "spread": "0.294"}]}]}, {"title": "10 minutes post dose 1 (n=37,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.714", "spread": "0.411"}, {"groupId": "OG001", "value": "1.668", "spread": "0.403"}, {"groupId": "OG002", "value": "1.620", "spread": "0.315"}]}]}, {"title": "25 minutes post dose 1 (n=37,37,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.712", "spread": "0.425"}, {"groupId": "OG001", "value": "1.695", "spread": "0.409"}, {"groupId": "OG002", "value": "1.644", "spread": "0.334"}]}]}, {"title": "10 minutes post dose 2 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.741", "spread": "0.430"}, {"groupId": "OG001", "value": "1.721", "spread": "0.420"}, {"groupId": "OG002", "value": "1.661", "spread": "0.332"}]}]}, {"title": "25 minutes post dose 2 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.735", "spread": "0.438"}, {"groupId": "OG001", "value": "1.714", "spread": "0.423"}, {"groupId": "OG002", "value": "1.669", "spread": "0.331"}]}]}, {"title": "10 minutes post dose 3 (n=34,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.775", "spread": "0.402"}, {"groupId": "OG001", "value": "1.731", "spread": "0.419"}, {"groupId": "OG002", "value": "1.689", "spread": "0.340"}]}]}, {"title": "25 minutes post dose 3 (n=35,38,26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.782", "spread": "0.415"}, {"groupId": "OG001", "value": "1.740", "spread": "0.419"}, {"groupId": "OG002", "value": "1.700", "spread": "0.345"}]}]}, {"title": "2 hours post dose 1 (n=36,37,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.784", "spread": "0.397"}, {"groupId": "OG001", "value": "1.754", "spread": "0.408"}, {"groupId": "OG002", "value": "1.704", "spread": "0.337"}]}]}, {"title": "4 hours post dose 1 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.732", "spread": "0.401"}, {"groupId": "OG001", "value": "1.722", "spread": "0.423"}, {"groupId": "OG002", "value": "1.684", "spread": "0.344"}]}]}, {"title": "6 hours post dose 1 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.667", "spread": "0.400"}, {"groupId": "OG001", "value": "1.725", "spread": "0.426"}, {"groupId": "OG002", "value": "1.660", "spread": "0.356"}]}]}]}, {"type": "PRIMARY", "title": "Change From Predose in Mean Heart Rate", "description": "Heart rate measured at various timepoints minus the heart rate at predose.", "populationDescription": "Intent to treat population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "beats per minute", "timeFrame": "predose, various timeframes up to 5 hours post last dose", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "40"}]}], "classes": [{"title": "15 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.6", "spread": "10.27"}, {"groupId": "OG001", "value": "0.5", "spread": "9.40"}, {"groupId": "OG002", "value": "2.3", "spread": "10.33"}]}]}, {"title": "30 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.2", "spread": "11.91"}, {"groupId": "OG001", "value": "2.0", "spread": "11.06"}, {"groupId": "OG002", "value": "2.5", "spread": "11.14"}]}]}, {"title": "60 min post dose 1 (n=51,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.7", "spread": "10.70"}, {"groupId": "OG001", "value": "4.4", "spread": "11.85"}, {"groupId": "OG002", "value": "6.5", "spread": "12.62"}]}]}, {"title": "15 min post dose 2 (n=50,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.8", "spread": "10.72"}, {"groupId": "OG001", "value": "2.8", "spread": "11.48"}, {"groupId": "OG002", "value": "5.5", "spread": "12.89"}]}]}, {"title": "30 min post dose 2 (n=47,50,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "10.0", "spread": "10.67"}, {"groupId": "OG001", "value": "4.5", "spread": "10.46"}, {"groupId": "OG002", "value": "6.3", "spread": "12.90"}]}]}, {"title": "60 min post dose 2 (n=46,50,37)", "categories": [{"measurements": [{"groupId": "OG000", "value": "13.2", "spread": "13.81"}, {"groupId": "OG001", "value": "4.7", "spread": "10.50"}, {"groupId": "OG002", "value": "9.5", "spread": "12.89"}]}]}, {"title": "30 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "11.9", "spread": "14.11"}, {"groupId": "OG001", "value": "5.6", "spread": "11.44"}, {"groupId": "OG002", "value": "9.0", "spread": "13.34"}]}]}, {"title": "60 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.7", "spread": "13.97"}, {"groupId": "OG001", "value": "8.6", "spread": "14.06"}, {"groupId": "OG002", "value": "10.0", "spread": "14.81"}]}]}, {"title": "1.5 hours post last dose (n=48,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.9", "spread": "11.73"}, {"groupId": "OG001", "value": "7.1", "spread": "12.65"}, {"groupId": "OG002", "value": "8.3", "spread": "15.95"}]}]}, {"title": "2 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.6", "spread": "12.13"}, {"groupId": "OG001", "value": "6.6", "spread": "10.77"}, {"groupId": "OG002", "value": "8.9", "spread": "12.69"}]}]}, {"title": "2.5 hours post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.8", "spread": "11.20"}, {"groupId": "OG001", "value": "5.5", "spread": "14.33"}, {"groupId": "OG002", "value": "7.8", "spread": "13.36"}]}]}, {"title": "3 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.7", "spread": "10.94"}, {"groupId": "OG001", "value": "5.9", "spread": "12.74"}, {"groupId": "OG002", "value": "6.4", "spread": "13.31"}]}]}, {"title": "3.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.9", "spread": "11.89"}, {"groupId": "OG001", "value": "5.1", "spread": "11.63"}, {"groupId": "OG002", "value": "7.9", "spread": "12.11"}]}]}, {"title": "4 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.6", "spread": "10.30"}, {"groupId": "OG001", "value": "4.6", "spread": "13.51"}, {"groupId": "OG002", "value": "7.4", "spread": "11.62"}]}]}, {"title": "4.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.9", "spread": "10.86"}, {"groupId": "OG001", "value": "4.9", "spread": "12.00"}, {"groupId": "OG002", "value": "6.9", "spread": "12.70"}]}]}, {"title": "5 hours post last dose (n=50,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.0", "spread": "12.03"}, {"groupId": "OG001", "value": "5.3", "spread": "12.41"}, {"groupId": "OG002", "value": "5.8", "spread": "12.55"}]}]}]}, {"type": "PRIMARY", "title": "Mean Systolic Blood Pressure", "description": "Systolic blood pressure measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).", "populationDescription": "Intent to treat population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "predose, various timeframes up to 5 hours post last dose", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "40"}]}], "classes": [{"title": "Predose (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "102.1", "spread": "10.80"}, {"groupId": "OG001", "value": "101.5", "spread": "9.86"}, {"groupId": "OG002", "value": "100.6", "spread": "10.36"}]}]}, {"title": "15 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "102.9", "spread": "10.90"}, {"groupId": "OG001", "value": "101.2", "spread": "11.07"}, {"groupId": "OG002", "value": "102.6", "spread": "11.42"}]}]}, {"title": "30 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "104.6", "spread": "12.08"}, {"groupId": "OG001", "value": "102.5", "spread": "10.20"}, {"groupId": "OG002", "value": "100.3", "spread": "9.78"}]}]}, {"title": "60 min post dose 1 (n=51,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "105.8", "spread": "9.31"}, {"groupId": "OG001", "value": "102.7", "spread": "9.82"}, {"groupId": "OG002", "value": "103.2", "spread": "10.82"}]}]}, {"title": "15 min post dose 2 (n=50,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "105.0", "spread": "11.20"}, {"groupId": "OG001", "value": "101.7", "spread": "9.42"}, {"groupId": "OG002", "value": "102.1", "spread": "12.20"}]}]}, {"title": "30 min post dose 2 (n=47,50,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "106.4", "spread": "10.32"}, {"groupId": "OG001", "value": "102.8", "spread": "9.26"}, {"groupId": "OG002", "value": "101.9", "spread": "9.81"}]}]}, {"title": "60 min post dose 2 (n=46,50,37)", "categories": [{"measurements": [{"groupId": "OG000", "value": "107.2", "spread": "12.05"}, {"groupId": "OG001", "value": "101.9", "spread": "11.18"}, {"groupId": "OG002", "value": "102.9", "spread": "9.95"}]}]}, {"title": "30 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "105.0", "spread": "12.22"}, {"groupId": "OG001", "value": "101.2", "spread": "11.72"}, {"groupId": "OG002", "value": "101.6", "spread": "12.60"}]}]}, {"title": "60 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "106.1", "spread": "10.32"}, {"groupId": "OG001", "value": "103.0", "spread": "11.87"}, {"groupId": "OG002", "value": "104.9", "spread": "11.03"}]}]}, {"title": "1.5 hours post last dose (n=48,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "104.8", "spread": "11.43"}, {"groupId": "OG001", "value": "101.9", "spread": "11.67"}, {"groupId": "OG002", "value": "103.0", "spread": "10.35"}]}]}, {"title": "2 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "104.6", "spread": "11.40"}, {"groupId": "OG001", "value": "103.4", "spread": "10.81"}, {"groupId": "OG002", "value": "101.8", "spread": "10.87"}]}]}, {"title": "2.5 hours post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "103.0", "spread": "12.41"}, {"groupId": "OG001", "value": "101.5", "spread": "10.58"}, {"groupId": "OG002", "value": "101.3", "spread": "10.10"}]}]}, {"title": "3 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "106.1", "spread": "12.28"}, {"groupId": "OG001", "value": "102.1", "spread": "10.84"}, {"groupId": "OG002", "value": "101.9", "spread": "11.57"}]}]}, {"title": "3.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "103.4", "spread": "10.00"}, {"groupId": "OG001", "value": "103.2", "spread": "11.38"}, {"groupId": "OG002", "value": "101.4", "spread": "9.41"}]}]}, {"title": "4 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "103.6", "spread": "11.26"}, {"groupId": "OG001", "value": "102.1", "spread": "10.14"}, {"groupId": "OG002", "value": "100.5", "spread": "10.48"}]}]}, {"title": "4.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "104.5", "spread": "10.50"}, {"groupId": "OG001", "value": "103.2", "spread": "10.96"}, {"groupId": "OG002", "value": "101.5", "spread": "9.25"}]}]}, {"title": "5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "106.7", "spread": "9.94"}, {"groupId": "OG001", "value": "104.1", "spread": "10.46"}, {"groupId": "OG002", "value": "102.1", "spread": "9.49"}]}]}]}, {"type": "PRIMARY", "title": "Change From Predose in Mean Systolic Blood Pressure", "description": "Mean systolic blood pressure measured at various timepoints minus the mean systolic blood pressure at predose", "populationDescription": "Intent to treat population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "predose, various timeframes up to 5 hours post last dose", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "40"}]}], "classes": [{"title": "15 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "10.58"}, {"groupId": "OG001", "value": "-0.4", "spread": "9.57"}, {"groupId": "OG002", "value": "2.0", "spread": "8.06"}]}]}, {"title": "30 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.6", "spread": "10.14"}, {"groupId": "OG001", "value": "0.9", "spread": "6.97"}, {"groupId": "OG002", "value": "-0.3", "spread": "7.68"}]}]}, {"title": "60 min post dose 1 (n=51,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.7", "spread": "8.60"}, {"groupId": "OG001", "value": "1.1", "spread": "9.54"}, {"groupId": "OG002", "value": "2.6", "spread": "7.97"}]}]}, {"title": "15 min post dose 2 (n=50,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.6", "spread": "8.94"}, {"groupId": "OG001", "value": "-0.3", "spread": "9.28"}, {"groupId": "OG002", "value": "1.6", "spread": "9.07"}]}]}, {"title": "30 min post dose 2 (n=47,50,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.3", "spread": "8.59"}, {"groupId": "OG001", "value": "0.8", "spread": "9.01"}, {"groupId": "OG002", "value": "1.4", "spread": "7.19"}]}]}, {"title": "60 min post dose 2 (n=46,50,37)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.0", "spread": "7.89"}, {"groupId": "OG001", "value": "-0.3", "spread": "8.98"}, {"groupId": "OG002", "value": "1.8", "spread": "8.87"}]}]}, {"title": "30 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.4", "spread": "10.72"}, {"groupId": "OG001", "value": "-0.4", "spread": "9.37"}, {"groupId": "OG002", "value": "1.1", "spread": "11.25"}]}]}, {"title": "60 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.5", "spread": "10.92"}, {"groupId": "OG001", "value": "1.5", "spread": "11.17"}, {"groupId": "OG002", "value": "4.4", "spread": "8.43"}]}]}, {"title": "1.5 hours post last dose (n=48,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.8", "spread": "9.70"}, {"groupId": "OG001", "value": "0.3", "spread": "10.22"}, {"groupId": "OG002", "value": "2.4", "spread": "8.06"}]}]}, {"title": "2 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.3", "spread": "10.31"}, {"groupId": "OG001", "value": "1.8", "spread": "10.18"}, {"groupId": "OG002", "value": "1.3", "spread": "9.44"}]}]}, {"title": "2.5 hours post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4", "spread": "10.12"}, {"groupId": "OG001", "value": "-0.0", "spread": "8.80"}, {"groupId": "OG002", "value": "0.7", "spread": "7.77"}]}]}, {"title": "3 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.9", "spread": "10.58"}, {"groupId": "OG001", "value": "0.6", "spread": "8.83"}, {"groupId": "OG002", "value": "1.3", "spread": "7.28"}]}]}, {"title": "3.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "8.87"}, {"groupId": "OG001", "value": "1.7", "spread": "10.18"}, {"groupId": "OG002", "value": "0.9", "spread": "7.06"}]}]}, {"title": "4 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "11.08"}, {"groupId": "OG001", "value": "0.6", "spread": "10.17"}, {"groupId": "OG002", "value": "-0.0", "spread": "8.36"}]}]}, {"title": "4.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.2", "spread": "10.37"}, {"groupId": "OG001", "value": "1.7", "spread": "9.61"}, {"groupId": "OG002", "value": "0.9", "spread": "8.26"}]}]}, {"title": "5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.5", "spread": "10.79"}, {"groupId": "OG001", "value": "2.5", "spread": "8.90"}, {"groupId": "OG002", "value": "1.6", "spread": "9.62"}]}]}]}, {"type": "PRIMARY", "title": "Mean Diastolic Blood Pressure", "description": "Diastolic blood pressure measured at various timepoints: predose and timepoints after each of the three dosings. Each treatment consists of one nebulization every 30 minutes over a 60 minute treatment interval (totaling 3 cumulative dosings at 0,30 and 60 minutes).", "populationDescription": "Intent to treat population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "predose, various timeframes up to 5 hours post last dose", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "40"}]}], "classes": [{"title": "Predose (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "62.5", "spread": "8.19"}, {"groupId": "OG001", "value": "63.2", "spread": "6.82"}, {"groupId": "OG002", "value": "63.6", "spread": "9.77"}]}]}, {"title": "15 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "61.4", "spread": "9.32"}, {"groupId": "OG001", "value": "62.0", "spread": "7.29"}, {"groupId": "OG002", "value": "62.5", "spread": "8.52"}]}]}, {"title": "30 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "60.8", "spread": "8.34"}, {"groupId": "OG001", "value": "62.5", "spread": "7.61"}, {"groupId": "OG002", "value": "61.6", "spread": "7.56"}]}]}, {"title": "60 min post dose 1 (n=51,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "63.4", "spread": "7.72"}, {"groupId": "OG001", "value": "62.5", "spread": "7.47"}, {"groupId": "OG002", "value": "62.3", "spread": "9.38"}]}]}, {"title": "15 min post dose 2 (n=50,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "61.7", "spread": "8.76"}, {"groupId": "OG001", "value": "63.3", "spread": "6.75"}, {"groupId": "OG002", "value": "60.8", "spread": "8.81"}]}]}, {"title": "30 min post dose 2 (n=47,50,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "63.1", "spread": "7.35"}, {"groupId": "OG001", "value": "62.2", "spread": "7.61"}, {"groupId": "OG002", "value": "61.7", "spread": "8.86"}]}]}, {"title": "60 min post dose 2 (n=46,50,37)", "categories": [{"measurements": [{"groupId": "OG000", "value": "62.8", "spread": "8.07"}, {"groupId": "OG001", "value": "62.0", "spread": "8.15"}, {"groupId": "OG002", "value": "62.3", "spread": "7.99"}]}]}, {"title": "30 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "63.4", "spread": "7.27"}, {"groupId": "OG001", "value": "62.0", "spread": "8.83"}, {"groupId": "OG002", "value": "61.6", "spread": "7.91"}]}]}, {"title": "60 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "63.5", "spread": "8.88"}, {"groupId": "OG001", "value": "62.1", "spread": "8.60"}, {"groupId": "OG002", "value": "62.5", "spread": "8.09"}]}]}, {"title": "1.5 hours post last dose (n=48,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "63.1", "spread": "9.09"}, {"groupId": "OG001", "value": "62.3", "spread": "7.90"}, {"groupId": "OG002", "value": "62.5", "spread": "9.03"}]}]}, {"title": "2 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "63.8", "spread": "10.79"}, {"groupId": "OG001", "value": "62.3", "spread": "6.87"}, {"groupId": "OG002", "value": "62.1", "spread": "9.62"}]}]}, {"title": "2.5 hours post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "60.7", "spread": "10.41"}, {"groupId": "OG001", "value": "59.7", "spread": "7.97"}, {"groupId": "OG002", "value": "62.3", "spread": "8.71"}]}]}, {"title": "3 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "63.2", "spread": "8.85"}, {"groupId": "OG001", "value": "61.4", "spread": "7.51"}, {"groupId": "OG002", "value": "62.5", "spread": "9.77"}]}]}, {"title": "3.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "62.0", "spread": "9.80"}, {"groupId": "OG001", "value": "60.5", "spread": "6.54"}, {"groupId": "OG002", "value": "62.6", "spread": "7.59"}]}]}, {"title": "4 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "62.9", "spread": "10.15"}, {"groupId": "OG001", "value": "63.1", "spread": "7.32"}, {"groupId": "OG002", "value": "59.9", "spread": "8.65"}]}]}, {"title": "4.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "62.6", "spread": "9.12"}, {"groupId": "OG001", "value": "62.2", "spread": "7.84"}, {"groupId": "OG002", "value": "61.9", "spread": "8.38"}]}]}, {"title": "5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "62.3", "spread": "8.75"}, {"groupId": "OG001", "value": "63.0", "spread": "7.40"}, {"groupId": "OG002", "value": "60.0", "spread": "8.59"}]}]}]}, {"type": "PRIMARY", "title": "Change From Predose in Mean Diastolic Blood Pressure", "description": "Mean diastolic blood pressure measured at various timepoints minus the predose diastolic blood pressure", "populationDescription": "Intent to treat population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "predose, various timeframes up to 5 hours post last dose", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "40"}]}], "classes": [{"title": "15 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.1", "spread": "8.60"}, {"groupId": "OG001", "value": "-1.1", "spread": "7.26"}, {"groupId": "OG002", "value": "-1.0", "spread": "10.23"}]}]}, {"title": "30 min post dose 1 (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.7", "spread": "7.69"}, {"groupId": "OG001", "value": "-0.6", "spread": "7.84"}, {"groupId": "OG002", "value": "-1.9", "spread": "7.27"}]}]}, {"title": "60 min post dose 1 (n=51,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "7.89"}, {"groupId": "OG001", "value": "-0.7", "spread": "7.71"}, {"groupId": "OG002", "value": "-1.3", "spread": "9.43"}]}]}, {"title": "15 min post dose 2 (n=50,51,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.1", "spread": "8.10"}, {"groupId": "OG001", "value": "0.1", "spread": "6.85"}, {"groupId": "OG002", "value": "-2.8", "spread": "9.65"}]}]}, {"title": "30 min post dose 2 (n=47,50,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "7.82"}, {"groupId": "OG001", "value": "-1.1", "spread": "7.59"}, {"groupId": "OG002", "value": "-1.9", "spread": "9.59"}]}]}, {"title": "60 min post dose 2 (n=46,50,37)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0", "spread": "7.08"}, {"groupId": "OG001", "value": "-1.3", "spread": "6.98"}, {"groupId": "OG002", "value": "-1.8", "spread": "6.91"}]}]}, {"title": "30 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "7.12"}, {"groupId": "OG001", "value": "-1.2", "spread": "7.34"}, {"groupId": "OG002", "value": "-1.9", "spread": "9.35"}]}]}, {"title": "60 min post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "8.84"}, {"groupId": "OG001", "value": "-1.1", "spread": "8.48"}, {"groupId": "OG002", "value": "-1.1", "spread": "8.31"}]}]}, {"title": "1.5 hours post last dose (n=48,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "8.00"}, {"groupId": "OG001", "value": "-0.9", "spread": "7.23"}, {"groupId": "OG002", "value": "-1.1", "spread": "9.38"}]}]}, {"title": "2 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.4", "spread": "10.16"}, {"groupId": "OG001", "value": "-0.9", "spread": "7.70"}, {"groupId": "OG002", "value": "-1.5", "spread": "9.39"}]}]}, {"title": "2.5 hours post last dose (n=49,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.9", "spread": "8.66"}, {"groupId": "OG001", "value": "-3.5", "spread": "7.36"}, {"groupId": "OG002", "value": "-1.3", "spread": "9.56"}]}]}, {"title": "3 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "8.45"}, {"groupId": "OG001", "value": "-1.8", "spread": "8.31"}, {"groupId": "OG002", "value": "-1.1", "spread": "10.49"}]}]}, {"title": "3.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "8.36"}, {"groupId": "OG001", "value": "-2.6", "spread": "6.66"}, {"groupId": "OG002", "value": "-1.0", "spread": "8.87"}]}]}, {"title": "4 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.5", "spread": "10.38"}, {"groupId": "OG001", "value": "-0.0", "spread": "7.63"}, {"groupId": "OG002", "value": "-3.7", "spread": "10.29"}]}]}, {"title": "4.5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2", "spread": "8.86"}, {"groupId": "OG001", "value": "-1.0", "spread": "7.64"}, {"groupId": "OG002", "value": "-1.7", "spread": "10.42"}]}]}, {"title": "5 hours post last dose (n=50,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "8.84"}, {"groupId": "OG001", "value": "-0.1", "spread": "8.06"}, {"groupId": "OG002", "value": "-3.6", "spread": "10.25"}]}]}]}, {"type": "PRIMARY", "title": "Mean Serum Potassium Levels", "populationDescription": "Intent to treat population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mEq/L", "timeFrame": "Predose, 2 hours and 6 hours postdose 1", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "39"}]}], "classes": [{"title": "Predose (n=51,52,39)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.25", "spread": "0.376"}, {"groupId": "OG001", "value": "4.27", "spread": "0.386"}, {"groupId": "OG002", "value": "4.31", "spread": "0.325"}]}]}, {"title": "2 hours post dose 1 (n=48,47,38)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.67", "spread": "0.423"}, {"groupId": "OG001", "value": "3.83", "spread": "0.391"}, {"groupId": "OG002", "value": "3.71", "spread": "0.410"}]}]}, {"title": "6 hours post dose 1 (n=48,49,38)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.99", "spread": "0.334"}, {"groupId": "OG001", "value": "3.95", "spread": "0.325"}, {"groupId": "OG002", "value": "3.87", "spread": "0.435"}]}]}]}, {"type": "PRIMARY", "title": "Change From Predose in Mean Serum Potassium", "description": "Change in mean serum potassium at the specified timepoint minus the predose value.", "populationDescription": "Intent to treat population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mEq/L", "timeFrame": "predose, 2 and 6 hours post dose", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "39"}]}], "classes": [{"title": "2 hours post dose 1 (n=48,47,38)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.58", "spread": "0.457"}, {"groupId": "OG001", "value": "-0.42", "spread": "0.407"}, {"groupId": "OG002", "value": "-0.62", "spread": "0.401"}]}]}, {"title": "6 hours post dose 1 (n=48,49,38)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.23", "spread": "0.307"}, {"groupId": "OG001", "value": "-0.31", "spread": "0.450"}, {"groupId": "OG002", "value": "-0.39", "spread": "0.424"}]}]}]}, {"type": "PRIMARY", "title": "Mean Serum Glucose Values", "populationDescription": "Intent to treat population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dl", "timeFrame": "Predose, 2 and 6 hours post dose 1", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "40"}]}], "classes": [{"title": "Predose (n=51,52,40)", "categories": [{"measurements": [{"groupId": "OG000", "value": "86.4", "spread": "15.59"}, {"groupId": "OG001", "value": "87.5", "spread": "15.43"}, {"groupId": "OG002", "value": "87.6", "spread": "17.41"}]}]}, {"title": "2 hours post dose 1 (n=48,47,39)", "categories": [{"measurements": [{"groupId": "OG000", "value": "114.5", "spread": "30.42"}, {"groupId": "OG001", "value": "108.6", "spread": "27.51"}, {"groupId": "OG002", "value": "120.6", "spread": "32.52"}]}]}, {"title": "6 hours post dose 1 (n=49,48,38)", "categories": [{"measurements": [{"groupId": "OG000", "value": "107.6", "spread": "18.43"}, {"groupId": "OG001", "value": "99.0", "spread": "15.78"}, {"groupId": "OG002", "value": "106.3", "spread": "15.64"}]}]}]}, {"type": "PRIMARY", "title": "Change From Predose in Mean Serum Glucose", "description": "Change in mean serum glucose at the specified timepoint minus the predose value.", "populationDescription": "Intent to treat population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dl", "timeFrame": "predose, 2 and 6 hours post dose", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "40"}]}], "classes": [{"title": "2 hours post dose 1 (n=48,47,39)", "categories": [{"measurements": [{"groupId": "OG000", "value": "27.1", "spread": "34.74"}, {"groupId": "OG001", "value": "22.4", "spread": "32.66"}, {"groupId": "OG002", "value": "32.9", "spread": "35.21"}]}]}, {"title": "6 hours post dose 1 (n=49,48,38)", "categories": [{"measurements": [{"groupId": "OG000", "value": "20.3", "spread": "22.49"}, {"groupId": "OG001", "value": "12.1", "spread": "20.59"}, {"groupId": "OG002", "value": "18.6", "spread": "23.11"}]}]}]}, {"type": "SECONDARY", "title": "Change From Predose of Mean Forced Expiratory Volume in One Second (FEV1)", "description": "Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. Change in FEV1 was calculated as postdose value minus the predose value at each visit.", "populationDescription": "Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "liters", "timeFrame": "predose, various postdose timepoints", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "38"}, {"groupId": "OG002", "value": "27"}]}], "classes": [{"title": "10 minutes post dose 1 (n=37,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.160", "spread": "0.102"}, {"groupId": "OG001", "value": "0.117", "spread": "0.112"}, {"groupId": "OG002", "value": "0.133", "spread": "0.105"}]}]}, {"title": "25 minutes post dose 1 (n=37,37,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.159", "spread": "0.139"}, {"groupId": "OG001", "value": "0.142", "spread": "0.151"}, {"groupId": "OG002", "value": "0.158", "spread": "0.125"}]}]}, {"title": "10 minutes post dose 2 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.199", "spread": "0.130"}, {"groupId": "OG001", "value": "0.169", "spread": "0.154"}, {"groupId": "OG002", "value": "0.175", "spread": "0.106"}]}]}, {"title": "25 minutes post dose 2 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.194", "spread": "0.153"}, {"groupId": "OG001", "value": "0.162", "spread": "0.166"}, {"groupId": "OG002", "value": "0.183", "spread": "0.137"}]}]}, {"title": "10 minutes post dose 3 (n=34,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.226", "spread": "0.144"}, {"groupId": "OG001", "value": "0.179", "spread": "0.160"}, {"groupId": "OG002", "value": "0.203", "spread": "0.148"}]}]}, {"title": "25 minutes post dose 3 (n=35,38,26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.226", "spread": "0.154"}, {"groupId": "OG001", "value": "0.188", "spread": "0.150"}, {"groupId": "OG002", "value": "0.205", "spread": "0.152"}]}]}, {"title": "2 hours post dose 1 (n=36,37,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.216", "spread": "0.139"}, {"groupId": "OG001", "value": "0.194", "spread": "0.146"}, {"groupId": "OG002", "value": "0.218", "spread": "0.149"}]}]}, {"title": "4 hours post dose 1 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.163", "spread": "0.150"}, {"groupId": "OG001", "value": "0.170", "spread": "0.175"}, {"groupId": "OG002", "value": "0.198", "spread": "0.150"}]}]}, {"title": "6 hours post dose 1 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.098", "spread": "0.128"}, {"groupId": "OG001", "value": "0.173", "spread": "0.165"}, {"groupId": "OG002", "value": "0.174", "spread": "0.166"}]}]}]}, {"type": "SECONDARY", "title": "Mean Peak Expiratory Flow Rate (PEFR)", "description": "PEFR is the fastest rate at which air can move through the airways during a forced expiration starting with fully inflated lungs as measured by peak flow meters.", "populationDescription": "Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "liters/second", "timeFrame": "predose, various postdose times", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "38"}, {"groupId": "OG002", "value": "27"}]}], "classes": [{"title": "predose (n=37,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.604", "spread": "0.949"}, {"groupId": "OG001", "value": "3.546", "spread": "0.928"}, {"groupId": "OG002", "value": "3.565", "spread": "0.675"}]}]}, {"title": "10 minutes post dose 1 (n=37,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.926", "spread": "0.900"}, {"groupId": "OG001", "value": "3.788", "spread": "0.950"}, {"groupId": "OG002", "value": "3.824", "spread": "0.613"}]}]}, {"title": "25 minutes post dose 1 (n=37,37,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.003", "spread": "0.893"}, {"groupId": "OG001", "value": "3.877", "spread": "0.950"}, {"groupId": "OG002", "value": "3.844", "spread": "0.698"}]}]}, {"title": "10 minutes post dose 2 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.053", "spread": "1.007"}, {"groupId": "OG001", "value": "3.890", "spread": "0.998"}, {"groupId": "OG002", "value": "3.925", "spread": "0.679"}]}]}, {"title": "25 minutes post dose 2 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.047", "spread": "0.982"}, {"groupId": "OG001", "value": "3.964", "spread": "0.912"}, {"groupId": "OG002", "value": "3.989", "spread": "0.652"}]}]}, {"title": "10 minutes post dose 3 (n=34,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.156", "spread": "0.960"}, {"groupId": "OG001", "value": "4.003", "spread": "0.993"}, {"groupId": "OG002", "value": "4.077", "spread": "0.711"}]}]}, {"title": "25 minutes post dose 3 (n=35,38,26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.176", "spread": "0.966"}, {"groupId": "OG001", "value": "4.007", "spread": "0.899"}, {"groupId": "OG002", "value": "4.017", "spread": "0.693"}]}]}, {"title": "2 hours post dose 1 (n=36,37,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.221", "spread": "0.961"}, {"groupId": "OG001", "value": "4.178", "spread": "1.013"}, {"groupId": "OG002", "value": "4.066", "spread": "0.668"}]}]}, {"title": "4 hours post dose 1 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.155", "spread": "0.984"}, {"groupId": "OG001", "value": "4.029", "spread": "1.061"}, {"groupId": "OG002", "value": "4.039", "spread": "0.663"}]}]}, {"title": "6 hours post dose 1 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.970", "spread": "0.938"}, {"groupId": "OG001", "value": "4.058", "spread": "1.075"}, {"groupId": "OG002", "value": "4.016", "spread": "0.628"}]}]}]}, {"type": "SECONDARY", "title": "Change From Predose in Mean Peak Expiratory Flow Rate (PEFR)", "description": "PEFR is the fastest rate at which air can move through the airways during a forced expiration starting with fully inflated lungs as measured by peak flow meters. Change in PEFR was calculated as postdose value minus the predose value at each visit.", "populationDescription": "Intent to treat population. Pulmonary function testing was only performed on subjects six years of age or older; there were no subjects five or younger who performed spirometry. Subject data for those who were misdosed with ARF 7.5mcg rather than ARF 15mcg in the open-label portion were excluded from these analyses.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "liters/second", "timeFrame": "predose, various postdose times", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "38"}, {"groupId": "OG002", "value": "27"}]}], "classes": [{"title": "10 minutes post dose 1 (n=37,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.322", "spread": "0.305"}, {"groupId": "OG001", "value": "0.242", "spread": "0.298"}, {"groupId": "OG002", "value": "0.259", "spread": "0.396"}]}]}, {"title": "25 minutes post dose 1 (n=37,37,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.399", "spread": "0.367"}, {"groupId": "OG001", "value": "0.320", "spread": "0.392"}, {"groupId": "OG002", "value": "0.279", "spread": "0.442"}]}]}, {"title": "10 minutes post dose 2 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.458", "spread": "0.363"}, {"groupId": "OG001", "value": "0.344", "spread": "0.369"}, {"groupId": "OG002", "value": "0.360", "spread": "0.406"}]}]}, {"title": "25 minutes post dose 2 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.452", "spread": "0.329"}, {"groupId": "OG001", "value": "0.419", "spread": "0.363"}, {"groupId": "OG002", "value": "0.424", "spread": "0.383"}]}]}, {"title": "10 minutes post dose 3 (n=34,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.524", "spread": "0.343"}, {"groupId": "OG001", "value": "0.457", "spread": "0.439"}, {"groupId": "OG002", "value": "0.513", "spread": "0.466"}]}]}, {"title": "25 minutes post dose 3 (n=35,38,26)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.539", "spread": "0.375"}, {"groupId": "OG001", "value": "0.462", "spread": "0.429"}, {"groupId": "OG002", "value": "0.449", "spread": "0.497"}]}]}, {"title": "2 hours post dose 1 (n=36,37,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.575", "spread": "0.385"}, {"groupId": "OG001", "value": "0.596", "spread": "0.596"}, {"groupId": "OG002", "value": "0.501", "spread": "0.408"}]}]}, {"title": "4 hours post dose 1 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.509", "spread": "0.345"}, {"groupId": "OG001", "value": "0.484", "spread": "0.440"}, {"groupId": "OG002", "value": "0.474", "spread": "0.449"}]}]}, {"title": "6 hours post dose 1 (n=36,38,27)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.324", "spread": "0.337"}, {"groupId": "OG001", "value": "0.513", "spread": "0.720"}, {"groupId": "OG002", "value": "0.451", "spread": "0.462"}]}]}]}, {"type": "SECONDARY", "title": "Plasma Concentration of (R,R) Formoterol", "description": "If the mean plasma concentration was 'below the limit of quantification' (BLQ) which was set as \\<=0.5 picograms/milliliter, the value is displayed as a zero.", "populationDescription": "PK population consisted of subjects who were in the intent-to-treat population and had any plasma concentration data available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "picogram/milliliter", "timeFrame": "predose, various postdose times", "groups": [{"id": "OG000", "title": "Levalbuterol 0.63 mg", "description": "Values represent participant experience when treated with levalbuterol during the cross-over portion of the study"}, {"id": "OG001", "title": "Arformoterol 7.5 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study"}, {"id": "OG002", "title": "Arformoterol 15 Mcg", "description": "Values represent the experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "39"}]}], "classes": [{"title": "predose (n=51,52,39)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.646", "spread": "3.4172"}, {"groupId": "OG001", "value": "0", "spread": "0.5159"}, {"groupId": "OG002", "value": "0.737", "spread": "2.7612"}]}]}, {"title": "25 minutes post dose 1 (n=50,46,36)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.402", "spread": "15.1253"}, {"groupId": "OG001", "value": "2.236", "spread": "13.0128"}, {"groupId": "OG002", "value": "1.659", "spread": "2.4584"}]}]}, {"title": "25 minutes post dose 2 (n=48,47,36)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.8858"}, {"groupId": "OG001", "value": "1.845", "spread": "2.8085"}, {"groupId": "OG002", "value": "3.325", "spread": "2.3515"}]}]}, {"title": "2 hours post dose 1 (n=50,51,38)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0000"}, {"groupId": "OG001", "value": "1.885", "spread": "1.7035"}, {"groupId": "OG002", "value": "4.189", "spread": "2.8207"}]}]}, {"title": "6 hours post dose 1 (n=50,50,37)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.8899"}, {"groupId": "OG001", "value": "0.874", "spread": "1.1988"}, {"groupId": "OG002", "value": "2.818", "spread": "1.7195"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "2", "eventGroups": [{"id": "EG000", "title": "Levalbuterol 0.63 mg", "description": "The experience of participants when treated with levalbuterol during the cross-over portion of the study.", "seriousNumAffected": 0, "seriousNumAtRisk": 51, "otherNumAffected": 10, "otherNumAtRisk": 51}, {"id": "EG001", "title": "Arformoterol 7.5 Mcg", "description": "The experience of participants when treated with arformoterol 7.5 mcg during the cross-over portion of the study.", "seriousNumAffected": 0, "seriousNumAtRisk": 52, "otherNumAffected": 7, "otherNumAtRisk": 52}, {"id": "EG002", "title": "Arformoterol 15 Mcg", "description": "The experience of participants when treated with arformoterol 15 mcg during the open-label portion of the study.", "seriousNumAffected": 0, "seriousNumAtRisk": 40, "otherNumAffected": 8, "otherNumAtRisk": 40}], "otherEvents": [{"term": "Abdominal Pain Upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 40}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Stomach Discomfort", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Toothache", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 2, "numAffected": 1, "numAtRisk": 40}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Gastroenteritis Viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Otitis Media", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 40}]}, {"term": "Urinary Tract Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 40}]}, {"term": "Viral Upper Respiratory Tract Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Blood Glucose Increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Blood Potassium Decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Electrocardiogram QT Prolonged", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Hyperglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 40}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 40}]}, {"term": "Neck Pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 40}]}, {"term": "Tremor", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Nasal Congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Oropharyngeal Pain", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 40}]}, {"term": "Rhinorrhoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (11.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 52}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 40}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "Sample size was determined outside of statistical considerations. All data recorded at/after Visit 8 for 6 subjects, misdosed with ARF 7.5mcg instead of ARF 15mcg in open-label period, were excluded from the planned efficacy, PK and safety analyses."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "In addition to the \\<60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish."}, "pointOfContact": {"title": "Respiratory Medical Director", "organization": "Sepracor Inc", "phone": "866-503-6351"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000000420", "term": "Albuterol"}, {"id": "D000068759", "term": "Formoterol Fumarate"}], "ancestors": [{"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000015149", "term": "Tocolytic Agents"}, {"id": "D000012102", "term": "Reproductive Control Agents"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M3767", "name": "Albuterol", "asFound": "APD", "relevance": "HIGH"}, {"id": "M21860", "name": "Pharmaceutical Solutions", "relevance": "LOW"}, {"id": "M304", "name": "Formoterol Fumarate", "asFound": "Heart Failure With Reduced Ejection Fraction", "relevance": "HIGH"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M17869", "name": "Tocolytic Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "PhSol", "name": "Pharmaceutical Solutions"}]}}, "hasResults": true}